KDR and cancer: Recently, Eissa et al. documented their latest discoveries regarding new theobromine derivatives inhibiting the VEGFR-2 enzyme, demonstrating promising antiproliferative activity in hepatic (HepG2) and breast (MCF-7) cancer cell lines (Scheme 11) [36,37,38].